Patent · US Active

Sequence specific antimicrobials

US12295993B2 · kind B2 · utility

0Cited by
11References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 3, 2020
Grant dateMay 13, 2025
Priority date
Expiry dateMar 14, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2795/10371
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are compositions and methods for selectively reducing the amount of antibiotic resistant and/or virulent bacteria in a mixed bacteria population, or for reducing any other type of unwanted bacteria in a mixed bacteria population. The compositions and methods involve targeting bacteria that are differentiated from other members of the population by at least one unique clustered regularly interspaced short palindromic repeats (CRISPR) targeted DNA sequence. The compositions and methods can be readily adapted to target any bacteria or any bacteria plasmid, or both.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.